Meridian Bioscience, Inc. (VIVO) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts VIVO Hot Sheet
Price: $4.55 --0%
Financial Fact:
Total operating expenses: 20.83M
Today's EPS Names:
CCEL, FNGR, FAST, More
Financial Fact:
Total operating expenses: 20.83M
Today's EPS Names:
CCEL, FNGR, FAST, More
Join SI Premium – FREE
Meridian Bioscience, Inc. (NASDAQ: VIVO) reported Q1 EPS of $0.20, $0.01 better than the analyst estimate of $0.19. Revenue for the quarter came in at $45.4 million versus the consensus estimate of $44.34 million.
Meridian Bioscience, Inc. reaffirmed FY2013 guidance.
For earnings history and earnings-related data on Meridian Bioscience, Inc. (VIVO) click here.
Meridian Bioscience, Inc. reaffirmed FY2013 guidance.
For earnings history and earnings-related data on Meridian Bioscience, Inc. (VIVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance
- Wells Fargo sees machinery sector recovery shifting to demand-driven
- Sanuwave Q2 2026 revenue tops revised guidance range
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
